| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030827308 |
| P356 | DOI | 10.1007/S40119-016-0063-5 |
| P3181 | OpenCitations bibliographic resource ID | 4787834 |
| P932 | PMC publication ID | 5125106 |
| P698 | PubMed publication ID | 27277596 |
| P2093 | author name string | Peter McKavanagh | |
| Claire McCune | |||
| Ian B. A. Menown | |||
| P2860 | cites work | A Randomized Trial of Intensive versus Standard Blood-Pressure Control | Q27231406 |
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| Idarucizumab for Dabigatran Reversal | Q28263802 | ||
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus | Q28297680 | ||
| Alogliptin after acute coronary syndrome in patients with type 2 diabetes | Q28297690 | ||
| Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation | Q30278369 | ||
| Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial | Q46059602 | ||
| Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). | Q47398929 | ||
| Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial | Q47734424 | ||
| A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial | Q48169319 | ||
| Outcomes 1 year after thrombus aspiration for myocardial infarction | Q48518414 | ||
| 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. | Q51542166 | ||
| A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. | Q51787525 | ||
| The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial. | Q52957839 | ||
| Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. | Q53228985 | ||
| Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease | Q61651367 | ||
| Increased mortality among patients taking digoxin--analysis from the AFFIRM study | Q85551923 | ||
| Ulnar Artery Interventions Non-Inferior to Radial Approach: AJmer Ulnar ARtery (AJULAR) Intervention Working Group Study Results | Q95526884 | ||
| Surgical ablation of atrial fibrillation during mitral-valve surgery. | Q30366105 | ||
| Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. | Q34043472 | ||
| 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 | ||
| Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors | Q34448983 | ||
| Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseas | Q34462504 | ||
| Efficacy and safety of alirocumab in reducing lipids and cardiovascular events | Q34467233 | ||
| Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. | Q34501375 | ||
| Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes | Q34670462 | ||
| Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | Q34673134 | ||
| A Review of the Key Clinical Trials of 2014. | Q35756614 | ||
| Outcomes of anatomical versus functional testing for coronary artery disease | Q35759198 | ||
| Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes | Q35769527 | ||
| Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation | Q35868819 | ||
| Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction | Q36369122 | ||
| Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial | Q36506245 | ||
| Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial | Q36787264 | ||
| Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial | Q36860117 | ||
| A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease | Q37098407 | ||
| Randomized trial of primary PCI with or without routine manual thrombectomy | Q37198036 | ||
| Diagnosis and treatment of familial hypercholesterolaemia | Q38082310 | ||
| Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome | Q38400415 | ||
| Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial | Q38400558 | ||
| Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial | Q38966384 | ||
| Advantages of Ambulatory Blood Pressure Monitoring in Assessing the Efficacy of Antihypertensive Therapy | Q38995259 | ||
| CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial | Q39027594 | ||
| Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk | Q39543970 | ||
| Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm | Q39580710 | ||
| Effect of Early Intervention With Positive Airway Pressure Therapy for Sleep Disordered Breathing on Six-Month Readmission Rates in Hospitalized Patients With Heart Failure | Q40037262 | ||
| Long-term use of ticagrelor in patients with prior myocardial infarction | Q40263764 | ||
| One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure | Q40336504 | ||
| A Leadless Intracardiac Transcatheter Pacing System | Q40340789 | ||
| Trial of Continuous or Interrupted Chest Compressions during CPR. | Q40341940 | ||
| Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker | Q40592343 | ||
| Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial | Q40787167 | ||
| Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease | Q41233814 | ||
| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial | Q43482729 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). | Q45038648 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-132 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | Cardiology and therapy | Q26842092 |
| P1476 | title | A Review of the Key Clinical Trials of 2015: Results and Implications | |
| P478 | volume | 5 |
| Q33890811 | Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials | cites work | P2860 |
Search more.